Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 2
2006 5
2007 14
2008 14
2009 8
2010 8
2011 9
2012 4
2013 8
2014 3
2015 4
2016 3
2017 3
2018 5
2019 5
2020 8
2021 11
2022 10
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study.
Kolligs F, Arnold D, Golfieri R, Pech M, Peynircioglu B, Pfammatter T, Ronot M, Sangro B, Schaefer N, Maleux G, Munneke G, Pereira H, Zeka B, de Jong N, Helmberger T; CIRT Principal Investigators. Kolligs F, et al. Among authors: peynircioglu b. JHEP Rep. 2022 Nov 25;5(2):100633. doi: 10.1016/j.jhepr.2022.100633. eCollection 2023 Feb. JHEP Rep. 2022. PMID: 36593888 Free PMC article.
Index of suspicion.
Hızarcioglu-Gulsen H, Aydemir Y, Gucer S, Berberoglu-Ates B, Hizal G, Peynircioglu B, Saltik-Temizel IN, Chawla H, Schwartzberg P, Nakhleh N, Loveridge-Lenza B, Ballance C, Sultan R, Naganathan S, Ngido F, Misra S. Hızarcioglu-Gulsen H, et al. Among authors: peynircioglu b. Pediatr Rev. 2014 Dec;35(12):531-7. doi: 10.1542/pir.35-12-531. Pediatr Rev. 2014. PMID: 25452662 No abstract available.
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
Maleux G, Albrecht T, Arnold D, Bargellini I, Cianni R, Helmberger T, Kolligs F, Munneke G, Peynircioglu B, Sangro B, Schaefer N, Pereira H, Zeka B, de Jong N, Bilbao JI; CIRT Principal Investigators. Maleux G, et al. Among authors: peynircioglu b. Cardiovasc Intervent Radiol. 2023 Jul;46(7):852-867. doi: 10.1007/s00270-023-03391-4. Epub 2023 Mar 13. Cardiovasc Intervent Radiol. 2023. PMID: 36914788 Free PMC article.
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.
Seidensticker M, Öcal O, Schütte K, Malfertheiner P, Berg T, Loewe C, Klümpen HJ, van Delden O, Ümütlü MR, Ben Khaled N, de Toni EN, Seidensticker R, Aghdassi A, Tran A, Bronowicki JP, Peynircioglu B, Sangro B, Pech M, Ricke J. Seidensticker M, et al. Among authors: peynircioglu b. JHEP Rep. 2023 Feb 15;5(5):100699. doi: 10.1016/j.jhepr.2023.100699. eCollection 2023 May. JHEP Rep. 2023. PMID: 36968218 Free PMC article.
Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome.
Ozercan M, Eser I, Kiremitci S, Peynircioglu B, Karayalcin S, Idilman R. Ozercan M, et al. Among authors: peynircioglu b. Hepatol Forum. 2021 Sep 15;2(3):120-121. doi: 10.14744/hf.2021.2021.0028. eCollection 2021 Sep. Hepatol Forum. 2021. PMID: 35784910 Free PMC article. No abstract available.
CIRSE Standards of Practice on Arterial Access for Interventions.
Memarian S, Krokidis M, O'Sullivan G, Peynircioglu B, Rossi M, Kashef E. Memarian S, et al. Among authors: peynircioglu b. Cardiovasc Intervent Radiol. 2023 Mar;46(3):302-309. doi: 10.1007/s00270-022-03349-y. Epub 2023 Jan 27. Cardiovasc Intervent Radiol. 2023. PMID: 36705706
CVID Associated with Systemic Amyloidosis.
Esenboga S, Çagdas Ayvaz D, Saglam Ayhan A, Peynircioglu B, Sanal O, Tezcan I. Esenboga S, et al. Among authors: peynircioglu b. Case Reports Immunol. 2015;2015:879179. doi: 10.1155/2015/879179. Epub 2015 Aug 4. Case Reports Immunol. 2015. PMID: 26346511 Free PMC article.
Comprehensive assessment and outcomes of patients with chronic periaortitis.
Yardimci GK, Ardali Düzgün S, Farisogullari B, Bölek EC, Eldem FG, Erden A, Kiliç L, Kösemehmetoglu K, Sağlam A, Peynircioğlu B, Akdoğan B, Hazirolan T, Karadag O. Yardimci GK, et al. Among authors: peynircioglu b. Clin Exp Rheumatol. 2022 May;40(4):801-810. doi: 10.55563/clinexprheumatol/araba3. Epub 2022 Mar 18. Clin Exp Rheumatol. 2022. PMID: 35349413 Free article.
113 results